Ticker Details
DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
IPO Date:	April 14, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$27.82B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.71 | 2.04%
Avg Daily Range (30 D):	$1.25 | 1.99%
Avg Daily Range (90 D):	$1.03 | 1.56%

Institutional Daily Volume
Avg Daily Volume:	1.25M
Avg Daily Volume (30 D):	4.61M
Avg Daily Volume (90 D):	3.89M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	20,977
Avg Institutional Trade:	$7.25M
Avg Institutional Trade (30 D):	$8.18M
Avg Institutional Trade (90 D):	$8.7M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$25.06M
Avg Closing Trade (30 D):	$67.27M
Avg Closing Trade (90 D):	$64.31M
Avg Closing Volume:	368.8K

News

May 15, 2026 @ 5:41 PM Diabetes Tech Player DexCom Lays Out 2030 Growth V... Source: Vandana Singh

May 12, 2026 @ 4:04 PM Sell in May and Go Away—Starting With These... Source: Bridget Bennett

May 5, 2026 @ 5:04 PM 9 Stocks That Could Defy the ’Sell in May a... Source: David Wagner

May 5, 2026 @ 5:03 PM 3 Reasons Analysts Love DexCom Source: Nathan Reiff

Apr 29, 2026 @ 2:30 PM Why Medtech Giants Are Quietly Paying Up for AI Di... Source: Usa News Group

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.14	$.69	$2.14
Diluted EPS	$2.09	$.67	$2.09
Revenue	$4.66B	$1.26B	$4.66B
Gross Profit	$2.8B	$792.7M	$2.8B
Net Income / Loss	$836.3M	$267.3M	$836.3M
Operating Income / Loss	$911.8M	$323M	$911.8M
Cost of Revenue	$1.86B	$466.9M	$1.86B
Net Cash Flow	$311.8M	$-917.8M	$311.8M
PE Ratio

Splits
Jun 13, 2022	4:1